Sartorius Stedim Biotech Launches Two Single-Use Sartocon® Loop Assemblies with Integrated Polyethersulfone (PESU) Membrane

sarto-stedim-bio logo

Assemblies save up to 60 percent on processing time and offer a safe approach to ultrafiltration of biologics and vaccines

Goettingen, Germany and Aubagne, France, September 30, 2016 / B3C newswire / -- Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, today announced its polyethersulfone membrane (PESU) is now integrated into two new, sterile Sartocon® benchtop and production scale filtration assemblies. Using these assemblies guarantees rapid and safe ultrafiltration of biologics and vaccines. Due to the fully enclosed design, the Sartocon® assemblies are ideal for safely purifying vaccines and recombinant proteins, as well as monoclonal antibody manufacturing. This makes them suitable for use in cGMP environments for process development, clinical trials and small-scale production batches.

The new single-use Sartocon® Self-contained Filter Loop Assembly has been developed for use with SSB’s unique control unit, the FlexAct® UD. While the Sartocon® Slice Self-contained Bag Loop Assembly has been designed for SSB’s benchtop crossflow system SARTOFLOW® Alpha plus SU. Both assemblies are supplied gamma sterilized and ready to use. The integrated PESU membrane is pre-wetted and flushed which saves hours in set-up and validation time, as well as eliminates the costs of using buffers and purified water to prepare the membrane.

Since the Sartocon® assemblies are designed with the same hydrodynamic flow path as SSB’s larger production scale filter devices and all device materials and accessories are manufactured to the same industrial quality-assured specifications, linear scale-up and process transfer is a simple process.

The PESU membrane inside the Sartocon® assemblies is available in several sizes and 10-300 KDa molecular weight cut-offs and is robust enough for use in broad pH and temperature ranges. These features combined with the Sartocon® assemblies’ single-use design, which prevents product cross-contamination, means they are perfect for use in R&D applications, Contract Manufacturing Organizations and multi-product facilities.

“Following on from the successful introduction in 2015 of the Hydrosart® membrane in our single-use Sartocon® filter loop assemblies, we made our PESU membrane for these applications available as well. Now customers can select from a broader range of membrane polymers and cut offs for ensuring optimal parameter for their specific process. When compared with reusable filter cassettes, we estimate that using these new single-use, PESU membrane-based assemblies will reduce processing time by around 60 percent and could save up to 2,000€ per batch on buffer and water costs”, Frank Meyeroltmanns, expert for crossflow-filtration at SSB explains.

Find more information about Sartocon® Loop Assemblies:
www.sartorius.com/en/filtration-and-purification/single-use-crossflow/ (for print publication)
https://goo.gl/RgusVW (for online publication)

Image Files

The single-use Sartocon® Self-contained Filter Loop Assembly has been developed for use with SSB’s control unit, the FlexAct® UD.
Download: www.sartorius.com/fileadmin/media/global/company/filter-loop-assembly.jpg

The Sartocon® Slice Self-contained Bag Loop Assembly has been designed for SSB’s benchtop crossflow system SARTOFLOW® Alpha plus SU.
Download: www.sartorius.com/fileadmin/media/global/company/bag-loop-assembly.jpg


A profile of Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading international supplier of products and services that enable the biopharmaceutical industry to develop and manufacture drugs safely and efficiently. As a total solutions provider, Sartorius Stedim Biotech offers a portfolio covering nearly all steps of biopharmaceutical manufacture. The company focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Headquartered in Aubagne, France, Sartorius Stedim Biotech is quoted on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech has a global reach. The company employs approx. 4,200 people, and in 2015 earned sales revenue of 884.3 million euros.


Contact

Dominic Grone
Senior Manager Corporate Communications
Sartorius Corporate Administration GmbH, Goettingen
+49.(0)551.308.3324
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.sartorius-stedim.com

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
Ok